Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy.

× No keyword cloud information.

52 in total

Review 1. Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.

Authors: Camilla Calvieri; Speranza Rubattu; Massimo Volpe
Journal: J Mol Med (Berl) Date: 2011-08-09 Impact factor: 4.599

2. Antibodies against the cardiac sodium/bicarbonate co-transporter (NBCe1) as pharmacological tools.

Authors: Verónica C De Giusti; Alejandro Orlowski; María C Villa-Abrille; Gladys E Chiappe de Cingolani; Joseph R Casey; Bernardo V Alvarez; Ernesto A Aiello
Journal: Br J Pharmacol Date: 2011-12 Impact factor: 8.739

3. Elevated expression of activated Na(+)/H(+) exchanger protein induces hypertrophy in isolated rat neonatal ventricular cardiomyocytes.

Authors: Fatima Mraiche; Larry Fliegel
Journal: Mol Cell Biochem Date: 2011-07-01 Impact factor: 3.396

4. Gender-specific effects of exercise on cardiac pathology in Na(+)/H(+) exchanger overexpressing mice.

Authors: Heather Vandertol Vanier; Fatima Mraiche; Xiuju Li; Larry Fliegel
Journal: Mol Cell Biochem Date: 2012-05-25 Impact factor: 3.396

5. Loss of the AE3 anion exchanger in a hypertrophic cardiomyopathy model causes rapid decompensation and heart failure.

Authors: Nabeel J Al Moamen; Vikram Prasad; Ilona Bodi; Marian L Miller; Michelle L Neiman; Valerie M Lasko; Seth L Alper; David F Wieczorek; John N Lorenz; Gary E Shull
Journal: J Mol Cell Cardiol Date: 2010-11-04 Impact factor: 5.000

Review 6. Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.

Authors: Gerald J Maarman; Rainer Schulz; Karen Sliwa; Ralph Theo Schermuly; Sandrine Lecour
Journal: Br J Pharmacol Date: 2017-02-24 Impact factor: 8.739

7. Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.

Authors: María V Correa; Mariela B Nolly; Claudia I Caldiz; Gladys E Chiappe de Cingolani; Horacio E Cingolani; Irene L Ennis
Journal: Pflugers Arch Date: 2013-12-11 Impact factor: 3.657

Review 8. Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes-cardiovascular and renal benefits in patients with chronic kidney disease.

Authors: Tamara Y Milder; Sophie L Stocker; Dorit Samocha-Bonet; Richard O Day; Jerry R Greenfield
Journal: Eur J Clin Pharmacol Date: 2019-08-03 Impact factor: 2.953

9. S0859, an N-cyanosulphonamide inhibitor of sodium-bicarbonate cotransport in the heart.

Authors: F F-T Ch'en; F C Villafuerte; P Swietach; P M Cobden; R D Vaughan-Jones
Journal: Br J Pharmacol Date: 2008-01-21 Impact factor: 8.739

Review 10. Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors: Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal: Heart Fail Rev Date: 2017-01 Impact factor: 4.214